Livzon Pharmaceutical Group Inc is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Zhuhai, Guangdong and currently employs 9,067 full-time employees. Livzon Pharmaceutical Group Inc is a China-based company principally engaged in the research, development, production and sale of pharmaceutical products. The firm's main businesses include chemical drug preparations, biological products, active pharmaceutical ingredients and intermediates, traditional Chinese medicine preparations, diagnostic reagents and equipment, commercial development and functional management. The firm's main products include Ilaprazole (Ilaprazole Enteric-Coated Tablets and Ilaprazole Sodium for Injection), a series of Bismuth Potassium Citrate products, Rabeprazole Sodium Enteric-Coated Capsules, Weisanlian (Bismuth Potassium Citrate Tablets/Tinidazole Tablets/Clarithromycin Tablets), Leuprorelin Acetate Microspheres for Injection, Urofollitropin for Injection, Menotropins for Injection, Voriconazole for Injection and others. The firm mainly operates its businesses in the domestic and overseas markets.
根據最新的財務報表(Form-10K),Livzon Pharmaceutical Group Inc. 的總資產為 $24,455,淨isProfitable}為 $2,061
LVZPF 的關鍵財務比率是什麼?
Livzon Pharmaceutical Group Inc. 的流動比率為 2.3,淨利潤率為 17.44,每股銷售為 $12.83。
Livzon Pharmaceutical Group Inc. 的收入按細分市場或地理位置如何劃分?
Livzon Pharmaceutical Group Inc. 最大收入來源為 Chemical Drug Preparations,在最近的收益報告中收入為 6,119,280,577。就地區而言,China 是 Livzon Pharmaceutical Group Inc. 的主要市場,收入為 9,976,999,763。
Livzon Pharmaceutical Group Inc. 是否盈利?
是的,根據最新的財務報表,Livzon Pharmaceutical Group Inc. 的淨利潤為 $2,061